Operation Warp Speed secures thousands of antibody doses, millions more likely needed

Operation Warp Speed’s deal for Regeneron’s COVID-19 neutralizing antibody cocktail could provide the U.S. government enough doses to treat the expected number of hospitalized patients over the next year, but tens of millions more will likely be needed for less severe patients and for prophylaxis.

The $450 million contract, announced Tuesday, is Operation Warp Speed’s first investment in a COVID-19 therapeutic, and HHS Secretary Alex Azar suggested it won’t be the last...